Cyclerion Therapeutics Inc Investor Webcast Event Transcript
Good morning everyone and welcome to Cyclerion's investor event focused on Praliciguat in diabetic nephropathy and heart failure with preserved ejection fraction. My name is Jessi Rennekamp. And I work in Cyclerion's Investor Relations and Corporate Communications Department.
We're really excited that you could be here with us today either in person or for those of you on the webcast.
Throughout today's presentation, we will be making forward-looking statements including statements about the timing and potential results of our clinical trials. These statements are based on current expectations and actual results could differ. For more information, please see the risk factors section of our SEC filings on our website, www.cyclerion.com.
We've put together an exciting agenda for today. The event will run until about 10 a.m. with time for Q&A at the end. If you're on the webcast and would like to ask a question,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
